Symbiotic Capital EB Fund, L.P. — Form D/A
Symbiotic Capital EB Fund, L.P. of LOS ANGELES, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2025-03-11. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-03-11
- Form: D/A
- Accession: 0002013520-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-506797
Issuer
- Name: Symbiotic Capital EB Fund, L.P.
- CIK: 0002013520
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: SYMBIOTIC CAPITAL, LOS ANGELES, CA, 90067
- Phone: 424-313-1550
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Arie Belldegrun | Director | LOS ANGELES, CA |
| Benjamin Belldegrun | Director | LOS ANGELES, CA |
| Himani Bhalla | Director | LOS ANGELES, CA |
| Joshua Bradley | Director | LOS ANGELES, CA |
| Russell Goldsmith | Director | LOS ANGELES, CA |
| Franz Humer | Director | LOS ANGELES, CA |
| Joshua Kazam | Director | New York, NY |
| - Symbiotic Capital Life Science Credit Fund GP, L.P | Promoter | LOS ANGELES, CA |
Other filings by this issuer (1)
More